-

NeuPath Health Announces Consulting Arrangement to Support Executive Changes

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced it has entered into a consulting agreement with one of the Company’s directors; Grishanth Ram.

To support the recently announced accelerated growth strategy and executive changes, NeuPath has entered into a consulting agreement with Grishanth Ram in an advisory capacity to support the Executive Chair in the transition to her new role. The term of the consulting agreement is for two months ending September 21, 2022.

Mr. Ram has been a member of the NeuPath board of directors since June 25, 2020. Prior to joining the board of directors, Mr. Ram served as the Chief Executive Officer of NeuPath from March 2018 to February 2019, and was NeuPath’s Executive Director from February 2019 to December 2019. Mr. Ram will continue to serve on NeuPath’s board of directors throughout the term of his consulting agreement.

About NeuPath

NeuPath is a vertically integrated health care provider utilizing research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by chronic pain, spinal injuries, sport-related injuries, and concussions. With equity ownership in seventeen clinics in Ontario and Alberta, NeuPath is building out a large-scale network to better serve patients across Canada. NeuPath is focused on transforming the hope of a better life into the reality of a life more fully lived.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS THE RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Contacts

Jeff Zygouras
info@neupath.com

NeuPath Health Inc.

TSX VENTURE:NPTH

Release Versions

Contacts

Jeff Zygouras
info@neupath.com

More News From NeuPath Health Inc.

NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the “Company”) today announced the timing and details for a planned leadership transition in 2026, as well as preliminary revenue and Adjusted EBITDA expectations for 2025. As part of its long-term succession planning, NeuPath’s President Stephen Lemieux will succeed Joseph Walewicz as Chief Executive Officer effective April 1, 2026. Joseph will continue his role on the Board of Directors and work closely with NeuPath’s leade...

NEUPATH HEALTH ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the “Company”) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice filed by NeuPath of its intention to renew its normal course issuer bid (“NCIB”). Under the NCIB, the Company may, during the 12-month period commencing December 4, 2025 and ending December 3, 2026 (or on such date that the Company completes its purchases or provides notice of termination), purchase up to 2,527,224 common share...

NEUPATH HEALTH REPORTS THIRD QUARTER 2025 RESULTS

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and nine months ended September 30, 2025 and information regarding the Company’s investor webinar on Thursday, November 13, 2025. All figures are in Canadian dollars, unless otherwise noted. “Our strong growth and improved cash flows demonstrate the...
Back to Newsroom